Compound information
- Natural Products
- ZC470249
- Molecular Formula
- C13H20N4O3
- Molecular Weight
- 280.1535405 g/mol
- Structure
-
- IUPAC Name
- tert-butyl 4-(pyrazole-1-carbonyl)piperazine-1-carboxylate
- InChI
- InChI=1S/C13H20N4O3/c1-13(2,3)20-12(19)16-9-7-15(8-10-16)11(18)17-6-4-5-14-17/h4-6H,7-10H2,1-3H3
- InChI Key
- PTANHFGPGVCEMD-UHFFFAOYSA-N
- SMILES
- CC(C)(C)OC(=O)N1CCN(C(=O)n2cccn2)CC1
- Source
- ZINC000299833529
Warheads
- Carbamate
-
ADMET Property
Physicochemical Property
Property | Value | Property | Value |
---|---|---|---|
Heavy Atom Count | 20 | Ring Count | 2 |
Heteroatom Count | 7 | Rotatable Bond Count | 0 |
Hydrogen Bond Acceptor Count | 5 | Hydrogen Bond Donor Count | 0 |
Topological Polar Surface Area | 67.67 Å2 | LogP | 1.552 |
LogS | -1.26 | LogD | 1.612 |
Absorption
Property | Value | Property | Value |
---|---|---|---|
Pgp inhibitor | 0.357 | Pgp substrate | 0.076 |
HIA | 0.959 | F20 % | 0.034 |
F30 % | 0.371 | Caco-2 | -4.394 |
MDCK | -4.867 |
Distribution
Property | Value | Property | Value |
---|---|---|---|
BBB Penetration | 0.592 | PPB | 52.214 |
VD | 0.912 | Fu | 0.345 |
Metabolism
Property | Value | Property | Value |
---|---|---|---|
CYP1A2 inhibitor | 0.006 | CYP1A2 substrate | 0.465 |
CYP2A6 substrate | 0.562 | CYP2B6 substrate | 0.588 |
CYP2C19 inhibitor | 0.284 | CYP2C19 substrate | 0.663 |
CYP2C8 substrate | 0.499 | CYP2C9 inhibitor | 0.02 |
CYP2C9 substrate | 0.95 | CYP2D6 inhibitor | 0.016 |
CYP2D6 substrate | 0.719 | CYP2E1 substrate | 0.855 |
CYP3A4 inhibitor | 0.002 | CYP3A4 substrate | 1.0 |
Excretion
Property | Value | Property | Value |
---|---|---|---|
T1/2 | 0.893 | CL | 5.187 |
Toxicity
Property | Value | Property | Value |
---|---|---|---|
hERG Blockers | 0.009 | Hepatotoxicity | 0.972 |
Mutagenicity | 0.109 | Rat Oral Acute Toxicity | 0.775 |
FDAMDD | 0.115 | Skin Sensitization | 0.005 |
Carcinogenicity | 0.96 | Eye Corrosion | 0.004 |
Eye Irritation | 0.067 | Respiratory Toxicity | 0.009 |
Environmental Toxicity
Property | Value | Property | Value |
---|---|---|---|
Bioconcentration Factors | 0.574 | IGC50 | 1.586 |
LC50FM | 2.098 | LC50DM | 0.374 |
Tox21 Pathway
Property | Value | Property | Value |
---|---|---|---|
NR-AR | 0.409 | NR-AR-LBD | 0.247 |
NR-AhR | 0.075 | NR-Aromatase | 0.021 |
NR-ER | 0.237 | NR-ER-LBD | 0.361 |
NR-PPAR-gamma | 0.123 | SR-ARE | 0.408 |
SR-ATAD5 | 0.274 | SR-HSE | 0.209 |
SR-MMP | 0.007 | SR-p53 | 0.015 |
Similar covalent inhibitors
Similar covalent drugs
No similar covalent drugs found for this compound.